Withdrawal. Medications and devices can help suppress withdrawal symptoms during detoxification. Detoxification is not in itself "treatment," but only the first step in the process. Patients who do not receive any further treatment after detoxification usually resume their drug use. One study of treatment facilities found that medications were used in almost 80 percent of detoxifications (SAMHSA, 2014). In November 2017, the Food and Drug Administration (FDA) granted a new indication to an electronic stimulation device, NSS-2 Bridge, for use in helping reduce opioid withdrawal symptoms. This device is placed behind the ear and sends electrical pulses to stimulate certain brain nerves. Also, in May 2018, the FDA approved lofexidine, a non-opioid medicine designed to reduce opioid withdrawal symptoms.
Since 1962, IVRS has grown into a continuum of care network offering an array of substance abuse services including detoxification, residential and outpatient treatment, aftercare, education, individual and group counseling, along with primary & secondary prevention services. Also we operate licensed, court-approved domestic violence batterer’s treatment alternatives. IVRS is headquartered in the City of Upland, and has facilities in the County San Bernardino (Southern California). Each year, IVRS serves approximately 5,000 individuals through a variety of substance abuse recovery, treatment, and prevention services. IVRS is run by qualified, caring multi-disciplinary team of administrators, counselors, therapists and support staff, including bilingual English/Spanish, who meet the California Department of Health Care Services licensing & certification requirements.